Retina
Optometry Needed More in Urgent Referral Care
The overburdened and dwindling subspecialty of neuro-ophthalmology inevitably means that ODs will see more patients who require prompt, accurate triaging.
09/27/2023
Lit Review Sheds Light on Early Myopic Maculopathy
Fundus tessellations’ prevalence varied from 43% to 94%, with an older demographic.
09/26/2023
Short- and Long-term Anti-VEGF Outcomes Differ in BRVO
For the latter, predictors of visual acuity included an intact EZ band and foveal bulge.
09/25/2023
Hyperbaric Oxygen Therapy Improves VA in RAO Patients
This unconventional method was found safe and effective when administered twice daily until revascularization of the central retinal artery.
09/21/2023
OCT-A Modification Reveals Retinal Capillaries in FAZ
Extending the time between scans allows the slower blood flow in this region to be imaged, which could potentially help distinguish diseased eyes earlier.
09/20/2023
Choroidal Assessment Helps Stratify Complication Risk in High Myopia
Researchers found that a baseline thickness cutoff of 40μm was significantly associated with the presence of myopic maculopathies.
09/15/2023
Reveal Hidden Retinal Disease Using FAF Imaging
This marker of metabolic activity lights up what’s beneath the surface.
09/15/2023
The Wild and Woolly World of Anti-VEGF in 2023
A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.
09/15/2023
Electrify Your Exams
ERGs document neuronal function—and dysfunction—in retinal conditions to aid differential diagnosis and monitor progression.
09/15/2023
Real-world Results of Gene Therapy Show Its Merits in Hereditary Vision Loss
Subretinal injection of voretigene neparvovec achieved stable median BCVA and mean retinal thickness, and improvements in low-level luminance VA up to 32 months, but new chorioretinal atrophy appeared in 50% of treated eyes.
09/14/2023
Upcoming Events
October 3, 2023
Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Damon Dierker, OD, and Jennifer Loh, MD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
October 5, 2023
Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Mile Brujic, OD, and Sheri Rowen, MD
Webinar: 7:00pm ET
Sponsored by Bausch + Lomb
October 11, 2023
Showcasing Inflammation and IOP Control
Location: Dickie Brennan's Palace Café
Presenters: Nora Cothran, OD, and Michael Chaglasian, OD
Presentation: 7:00pm CT
Sponsored by Bausch + Lomb
